OPY Acquisition Corp. I
OHAAU
NASDAQ Global Market10.76
USD
+0.32
- -
OPY Acquisition Corp. I
OHAAU
(NASDAQ Global Market)
Recent
price
10.76
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- OPY Acquisition Corp. I (OHAAU) operates as a blank check company whose purpose centers on effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, with an initial focus on the healthcare industry including novel therapeutics, medical devices, and services that improve healthcare outcomes; it conducts no significant operations or generates revenues prior to completing such a transaction. The company offers Class A common stock and redeemable warrants through its publicly traded units, holds funds in a trust account for potential redemptions, and targets institutional and retail investors seeking exposure to future business combinations. Founded in 2020 and headquartered at 85 Broad Street in New York, New York, OPY Acquisition Corp. I maintains operations primarily in the United States. In a major development, the company announced in December 2023 its inability to consummate an initial business combination despite extensions to its deadline, leading to the cancellation of public shares effective December 28, 2023, redemption of shares from trust account proceeds, suspension of trading, Nasdaq delisting via Form 25, and termination of SEC registration via Form 15, marking its dissolution and liquidation. Prior to liquidation, OPY Acquisition Corp. I completed an upsized $110 million initial public offering in October 2021, closing the full over-allotment option. Sponsored by affiliates of Oppenheimer Holdings Inc., the company conducted an extensive target search but determined no viable high-quality transaction amid challenging SPAC market conditions.